ACTIVE HALF-LIFE
24 hours
CLASSIFICATION
Selective Estrogen Receptor Modulator (SERM)
ACNE
None
WATER RETENTION
None
HBR
None
HEPATOTOXICITY
None
AROMATIZATION
None
MANUFACTURER
Deus Medical
LAB TEST
Available in Document
WAREHOUSE
EU Warehouse 2
SUBSTANCE
Raloxifene
Introducing EVIMED 60 (Raloxifene HCL), a powerful addition to the selective estrogen receptor modulators (SERMs) family. Specifically formulated for women, this innovative medication is designed to prevent and treat osteoporosis post-menopause. By effectively reducing bone loss and enhancing bone strength, EVIMED 60 plays a crucial role in lowering the risk of fractures. Furthermore, it may also diminish the chances of developing a certain type of breast cancer after menopause, offering an extra layer of protection for your health.